阴道输出的快溶抗体片 (FDAT) 用于按需的非激素避孕和多用途保护
Keiichiro Kushiro1, Scott Hammers1, Yong Zhu2
1Mucommune, LLC, Morrisville, NC 27560, USA.
概括
新的快速溶解抗体片 (FDAT) 提供了一种方便的方法来提供非激素避孕药和治疗性传播感染,如单纯疹病毒 (HSV). 这些FDAT确保功能性抗体的快速,稳定的释放,以改善女性生殖健康.
科学领域:
- 生物医学工程 生物医学工程
- 生殖健康 生殖健康
- 药物输送系统 药物输送系统
背景情况:
- 有限的非荷尔蒙避孕选择和阻止性传播疾病 (STD) 的方法,如简单疹病毒 (HSV).
- 单克隆抗体 (mAbs) 的直接阴道输送显示出希望,但在方便和稳定的剂量形式方面面临挑战.
- 在女性生殖健康中需要创新的生物药物输送系统.
研究的目的:
- 开发和验证快速溶解抗体片 (FDAT),用于直接通过阴道输送单克隆抗体 (mAbs).
- 证明FDATs在提供抗HSVmAb和抗精子mAb方面的有效性.
- 评估FDAT平台的稳定性,安全性和耐受性.
主要方法:
- 开发用于快速释放功能性抗体的快速溶解抗体片 (FDAT).
- 携带抗HSV mAb (HSV8) 和抗精子 mAb (MM008) 的FDATs的配方.
- 在人类宫性阴道粘液和在羊体内的体内研究中进行了ex vivo测试.
主要成果:
- 在模拟和活体阴道环境中,FDAT能够在几秒到几分钟内完全释放功能性mAbs.
- HSV8-FDAT实现了均的阴道分布,并保持了对HSV的中和活性.
- MM008-FDAT迅速消除了运动精子,在绵羊研究中,FDATs显示稳定性和安全性.
结论:
- FDAT平台提供了一种有希望,方便和稳定的方法,用于通过阴道输送生物药物.
- 这项技术有可能推进非荷尔蒙避孕和性传播疾病预防,增强女性生殖健康.
- FDAT代表了改善妇女健康治疗干预措施的重要一步.
相关概念视频
Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...


